Securities code: Cofoe Medical Technology Co.Ltd(301087) securities abbreviation: Cofoe Medical Technology Co.Ltd(301087)
Cofoe Medical Technology Co.Ltd(301087)
Record of investor relations activities
No.: 2022011
Investor relations activity category □ specific object research □ analyst meeting
□ media interview \uf0a3 performance briefing
□ press conference □ Roadshow
\uf0a3 site visit
□ other teleconferences
Name and personnel of participants Huaan Securities Co.Ltd(600909) Tan Guochao and Li Chan; Yinhua Fund Wu Jingxiu, sun Haoyang, Zhou Jing, sun Beilin, Wei Zhuo and Dai Fangxian.
Time: May 18, 2022
Place Cofoe Medical Technology Co.Ltd(301087) conference room
Name of receptionist of listed company
Director / Vice President / Secretary Xue Xiaoqiao
name
1. Which items have great growth potential this year?
A: since last year, the company has successively launched a number of important new products on the market, including a variety of blood glucose monitoring products, uric acid series, blood oxygen series, covid-19 antigen detection series, gastric Helicobacter pylori detection test paper, early pregnancy test paper, oxygen generator, sodium hyaluronate repair paste, etc. the follow-up company is engaged in rehabilitation aids, medical care More new products will be launched in the fields of respiratory support, gradually expand the independent production capacity, and realize the rapid growth of relevant categories with the help of the company’s channel advantages.
2. CGM R & D progress?
The CGM project of the main company of investor relations activities has completed the preparation content introduction process and small batch cytotoxicity test of small batch sensor electrodes, electronic mediator materials and outer membrane materials. At present, the research and development progress is relatively smooth, and the subsequent registration and clinical trial will be carried out steadily.
3. What are the company’s future M & A plans?
A: M & A is a supplementary means for the company to improve its industrial layout. The company will mainly explore the possibility of M & A along the upstream and downstream of the industrial chain, give full play to the coordination effect, optimize the company’s product structure and enhance its core competitiveness. 4. Progress of M & A and integration of Beijia and giri medical?
A: beibeijia has completed the delivery in early April. Through the agent operation two months before the delivery, the overall operation effect is in line with expectations. The company is promoting the R & D and upgrading of back top products through joint research with universities and medical institutions, and establishing the public’s correct cognition and application of posture correction belt products in the form of medical science popularization
Style. At the same time, based on the company’s rich experience and comprehensive operation ability in the field of Internet sales, as well as the extensive layout of offline pharmacies, supermarkets and other channels, the company will promote the sales of back-to-back Jia series rehabilitation products. Giri medical has completed the delivery in December 2021. Giri medical was an upstream supplier of the company before, and the integration between the two sides was very smooth.
5. The development of healthy ear hearing in the first quarter and the future development plan?
At present, there are more than 400 hearing aid fitting centers for healthy ear hearing, and more than 60 stores were newly expanded in the first quarter. In February this year, Jianer hearing acquired 80% equity of Chengdu Yier and carried out expansion activities in Sichuan Based on Chengdu Yier. The company comprehensively upgraded the store image in Sichuan and introduced a full set of operation and management system of Jianer hearing.
Affected by covid-19 epidemic, the company will prudently and steadily promote the layout of hearing aid fitting center this year. At the same time, the company will polish and improve the operation management system of hearing aid fitting center and improve the professional service level and operation management efficiency by strengthening regional management and improving the cascade training system of fitting teachers.
Annex list (if any) none
Date: May 18, 2022
